Dr. Chao has interest in the following research areas: (1) identification of prognostic biomarkers for cancer disease progression; (2) treatment adverse events among cancer patients; (3) long-term outcomes among cancer survivors; and (4) Utilization of HPV vaccine. Currently, I am leading several cancer epidemiology projects at Kaiser Permanente Southern California (KPSC), with an emphasis on non-Hodgkin lymphoma and HIV-related malignancies. I am particularly interested in the area of tissue based research as well as patient outcomes. In my project of HIV-related diffuse large B-cell lymphoma, we performed tissue microassay and IHC staining to investigate the prognostic significance of several viral markers, cell cycle regulators and anti-apoptotic proteins, utilizing the comprehensive clinical information available at KPSC. Several of my other studies also focused on cancer patient outcomes. For example, in one study we examined clinical predictors for cancer survival outcomes among patients with HIV. In another study, we examined the associations between chronic co-morbidities and risk of chemotherapy-induced febrile neutropenia. Recently, in collaboration with City of Hope, we have completed a cervical cancer survivorship study in which we recruited and administer psychosocial interventions to cervical cancer survivors. My other studies aim at studying the risk/protective factors for cancer development and progression, including the role of certain dietary intake, pharmacological agents and immunomodulation. For example, an on-going R01 study for which I serve as the KPSC site PI investigates the potential protective effect of statins on risk of lymphoid malignancies. I am committed to dedicate my career to cancer research with the goal to improve the outcomes of cancer patients as well as cancer prevention.
Dr. Chao has been a Research Scientist at the Department of Research and Evaluation, Kaiser Permanente Southern California since 2007, and an adjunct Assistant Professor at the Department of Epidemiology, UCLA since 2009. Dr. Chao received her bachelor's degree in Zoology from the National Taiwan University, her master of science degree in Immunology and Infectious Diseases from the Harvard University, and her Ph.D. degree in Epidemiology from the UCLA. Dr. Chao is a member of the UCLA Josson Comprehensive Cancer Center.
Please check with the faculty member or their office about availability to serve during current academic period.
Chao Chun, Klein Nicola P, Velicer Christine M, Sy Lina S, Slezak Jeff M, Takhar Harpreet, Ackerson Bradley, Cheetham T Craig, Hansen John, Deosaransingh Kamala, Emery Michael, Liaw Kai-Li, Jacobsen Steven J Surveillance of Autoimmune Conditions following Routine Use of Quadrivalent Human Papillomavirus Vaccine.. Journal of internal medicine. 2011; .
Chao Chun, Xu Lanfang, Abrams Donald I, Towner William J, Horberg Michael A, Leyden Wendy A, Silverberg Michael J HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.. AIDS (London, England). 2011; 25(14): 1771-7.
Chao Chun, Li Qiaowu, Zhang Feng, White Emily Alcohol consumption and risk of lung cancer in the VITamins And Lifestyle Study.. Nutrition and cancer. 2011; 63(6): 880-8.
Chao Chun, Xu Lanfang, Abrams Donald, Leyden Wendy, Horberg Michael, Towner William, Klein Daniel, Tang Beth, Silverberg Michael Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.. AIDS (London, England). 2010; 24(11): 1765-70.
Chao Chun, Velicer Christine, Slezak Jeff M, Jacobsen Steven J Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization.. American journal of epidemiology. 2010; 171(3): 357-67.
Chao Chun, Haque Reina, Van Den Eeden Stephen K, Caan Bette J, Poon Kwun-Yee T, Quinn Virginia P Red wine consumption and risk of prostate cancer: the California men's health study.. International journal of cancer. Journal international du cancer. 2010; 126(1): 171-9.